Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 13/20 | 0.60 |
| ▸ | CNR2 | P34972 | 9/20 | 0.60 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CTSG | P08311 | 1/20 | 0.47 |
| ▸ | CMA1 | P23946 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3530500 | 0.85 | FDFT1 (0.58) | CNR1CNR2FDFT1 | |
| SCHEMBL13804771 | 0.84 | FDFT1 (0.57) | CNR1CNR2FDFT1 | |
| SCHEMBL3527193 | 0.84 | FDFT1 (0.57) | CNR1CNR2FDFT1 | |
| SCHEMBL13804850 | 0.84 | CNR1 (0.65) | CNR1CNR2FDFT1 | |
| SCHEMBL3527893 | 0.84 | CNR1 (0.65) | CNR1CNR2FDFT1 | |
| SCHEMBL13804828 | 0.83 | FDFT1 (0.61) | CNR1CNR2FDFT1 | |
| SCHEMBL3523476 | 0.83 | FDFT1 (0.61) | CNR1CNR2FDFT1 | |
| SCHEMBL13804810 | 0.82 | FDFT1 (0.60) | CNR1CNR2FDFT1 | |
| SCHEMBL13804761 | 0.81 | FDFT1 (0.61) | CNR1CNR2FDFT1 | |
| SCHEMBL3523445 | 0.80 | CNR1 (0.60) | CNR1CNR2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080171692-A1 | Substituted amides | MERCK SHARP & DOHME CORP. | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171692-A1 | Substituted amides | CNR1, CNR2, FAAH | CNR1 1/4885CNR2 2/4885FDFT1 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.